Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study

Eitemau Tebyg

• Managing infertility with the follitropin alfa prefilled pen injector – patient considerations
  gan: Bühler, Klaus
  Cyhoeddwyd: (2015)
• A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology
  gan: Bühler, Klaus, et al.
  Cyhoeddwyd: (2014)
• Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction
  gan: Nawroth, Frank, et al.
  Cyhoeddwyd: (2015)
• Pharmacoeconomic analysis of the application of follitropin alfa in combination with assisted reproductive technologies
  gan: K. A. Perova, et al.
  Cyhoeddwyd: (2022-04-01)
• Human factors engineering and design validation for the redesigned follitropin alfa pen injection device
  gan: Mahony, Mary C, et al.
  Cyhoeddwyd: (2015)